
In the last 10 years many advances have been achieved in the treatment of patients with Crohn's disease, particularly in the field of biological zzso zzso a zzso necrosis factor alpha zzso has been recently added to the therapeutic zzso for Crohn's disease and has greatly improved our treatment zzso zzso has demonstrated efficacy in the induction and maintenance of zzso in zzso and zzso Crohn's disease both in adults and zzso However, the potential development of zzso and the risk of serious adverse events limit the possibility of a wider use of zzso zzso for less zzso and higher effectiveness in the last years a number of biological agents have been zzso zzso a fully human zzso zzso anti zzso necrosis factor zzso has resulted effective and safe in patients with Crohn's disease, both zzso and zzso to zzso presenting also the advantage of subcutaneous way of zzso zzso also showed promising results in terms of efficacy but its safety is still under zzso To date no particular advances have been recently appeared in the literature concerning conventional zzso zzso Surgery remains a valid resort for zzso zzso zzso stem cell transplantation represents a new hope as rescue treatment for patients with severe zzso Crohn's zzso 

